文献速递泌尿生殖儿科影像USDSA

对比增强排尿超声在膀胱输尿管反流评估中的应用:时机已到

Contrast-enhanced voiding urosonography in the assessment of vesical-ureteral reflux: the time has come.
PubMed 文献 · Radiol Med · 2021-05-05

膀胱输尿管反流(VUR)可致反复感染、肾瘢痕及慢性肾病,是肾血管性高血压的重要危险因素。自1994年引入对比增强排尿超声(ceVUS)以来,其逐渐作为排尿性膀胱尿道造影(VCUG)的替代技术用于VUR诊断与分级,因无电离辐射且敏感性高而受大量文献支持,但现行指南仍仅纳入VCUG。随着超声软件进步及FDA与EMA批准膀胱内超声造影剂使用,学界需重新评估ceVUS在VUR诊断与随访中的作用,其可能广泛取代VCUG作为参考方法,而将VCUG保留于复杂解剖设置下的术前评估。

要点

  • ceVUS无电离辐射且敏感性高,可作为VUR诊断与分级的VCUG替代技术。
  • 现行指南仍仅纳入VCUG诊断VUR,ceVUS尚未被常规推荐。
  • ceVUS可能广泛取代VCUG,VCUG保留用于复杂解剖的术前评估。

核心结论

  • ceVUS因无电离辐射且敏感性高,可能广泛取代VCUG作为VUR诊断与随访的参考方法,VCUG则保留用于最复杂解剖设置下的术前评估。

研究设计与样本

  • 综述性文章,总结ceVUS自1994年引入以来作为VCUG替代技术用于VUR诊断与分级的文献证据与指南现状。

临床应用与阅片要点

  • 日常可优先考虑ceVUS评估VUR以避免电离辐射,但需注意现行指南仍仅纳入VCUG。
  • 对复杂解剖需术前评估的病例,仍应保留VCUG。

局限性

  • 原文未报告系统检索范围与纳入文献数量,属叙述性综述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Vesicoureteral reflux (VUR) is a pathological condition contradistinguished by monolateral or bilateral retrograde flow of urine from the bladder to the ureter and to the kidney. If not properly recognized and treated, VUR can potentially be associated to several complications such as recurrent infections and possible secondary scars with Chronic Kidney Disease (CKD). Furthermore, it represents an important risk factor for nephrovascular hypertension. During the last 20 years, the diagnostic approach to this entity has passed through several, drastic changes: indeed, since its introduction in 1994 contrast-enhanced voiding urosonography (ceVUS) has gradually accompanied the voiding cystourethrography (VCUG) as alternative imaging technique for the diagnosis and staging of VUR. Despite a large number of papers has strongly encouraged its use in clinical practice, due to the lack of ionizing radiations and its high sensitivity rate, to date almost all the guidelines only include the VCUG for VUR diagnosis. The introduction of technologically advanced US software and the approval of the intravesical administration of ultrasound contrast agents by the Food and Drug Administration (FDA) and by the European Medicine Agency (EMA) have to induce the Scientific Community to a deep revaluation of the role of ceVUS in the diagnosis and follow-up of VUR: urosonography might extensively replace VCUG as the reference method, reserving to cystourethrography a role in the most complex anatomic settings for pre-surgical evaluation.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Sofia C, Solazzo A, Cattafi A, et al. Contrast-enhanced voiding urosonography in the assessment of vesical-ureteral reflux: the time has come. Radiol Med. 2021. PMID: 33954899. doi:10.1007/s11547-021-01360-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。